S.Biomedics Co., Ltd.
304360 | KO
Overview
Corporate Details
- ISIN(s):
- KR7304360001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 성동구 성수이로26길 28 (성수동2가, 우일벤처타운) 4층, 성동구
- Website:
- https://www.sbiomedics.com/eng/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-07-11 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 107.2 KB | ||
| 2025-06-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 104.1 KB | ||
| 2025-06-16 00:00 |
Share Issue/Capital Change
전환가액의조정 (제6회차)
|
Korean | 10.9 KB | ||
| 2025-06-16 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-06-13 00:00 |
Share Issue/Capital Change
전환가액의조정 (제5회차)
|
Korean | 10.9 KB | ||
| 2025-06-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 107.6 KB | ||
| 2025-05-14 00:00 |
Regulatory Filings
신규시설투자등
|
Korean | 7.5 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 113.8 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 28.3 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.3 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.3 KB | ||
| 2025-03-25 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 160.7 KB |
Automate Your Workflow. Get a real-time feed of all S.Biomedics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for S.Biomedics Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for S.Biomedics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Malaysia
N/A
Discovering novel gene editing tools from nature for curative genetic medicines.
United States of America
MGX
United States of America
MGX
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
United States of America
HYFT
Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.
Sweden
MIPS
Sweden
MIPS
Japan
3636
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Sweden
MODTX
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC
Poland
MOC
Clinical-stage biotech developing radiopharmaceuticals for oncology and therapies for rare diseases.
United States of America
MNPR
United States of America
MNPR
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland
MURA
Ireland
MURA
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
United Kingdom
N4P